In my previous posts, I addressed the low rate of vaccine adoption. Mistrust is spreading mainly among healthcare workers. The leading U.S. Covid-19 vaccine makers sank on Tuesday as Moderna slumped 11% and BioNTech fell almost 10%. And now the mistrust is bitting the stock market and mainly “vaccine” stocks.
Howard University Hospital in Washington, D.C., a major healthcare provider for the Black community, received 725 doses of the Pfizer vaccine Dec. 15 and expects to receive a second shipment this week. As of Dec. 18, only about 600 of the hospital’s 1,900 employees had signed up for the shots, according to Kaiser Health News.
An internal hospital survey of about 350 employees in early November showed that 70 percent were not willing to take the COVID-19 vaccine or would not take it immediately after it became available.
At Doctors Hospital at Renaissance in Edinburg, Texas, so many workers declined the COVID-19 vaccine that the hospital offered doses to other medical workers in the region, according to ProPublica.
I highlighted in our Global Macro Insight several days ago that we could face off in the coming weeks one of the most important health and financial scandal.